The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
The biosimilars business generated Rs. 10,431 crore in FY26 revenue, up 16% year-on-year
Initiative launched with Tata 1mg to benefit 70,000 people across 70 remote villages in Kalahandi region
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
Former DCGI and now advisor to UP CM highlights medical device growth, healthcare expansion, and investment opportunities in the state
Hair care & quick commerce shine
With robust FY26 growth, plans AI-led diagnostics and genomic testing expansion
The partnership will focus on diabetes and NCD awareness, rare disease screening, and deployment of mobile medical units
The company highlights role of integrated genomics and multi-omics research at the Illumina Multiomics Summit India 2026 held in New Delhi and Bengaluru
The facility combines advanced diagnostics, bone marrow transplant evaluation, prenatal awareness, and multidisciplinary support services
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
